About IND
| No. | Applicant | Approval date | Product name | Test subject | Testing institution | Test step | Clinical trial | Joint research (Rights holder) |
|---|---|---|---|---|---|---|---|---|
| 13 | Hanpoong Pharm & Foods Ltd. | May. 06, 2022 | Mecasin | Phase 2a clinical trial investigating the safety and optimal dosage of Mecasin for mild and moderate Alzheimer's disease: Manifold, randomized stratified, double-blind, multiple-dose, placebo-controlled study | Wonkwang University Gwangju Medical Center Wonkwang University Sanbon Hospital |
Stage 2a | Daegu Haany University | |
| 12 | Hanpoong Pharm & Foods Ltd. | Jul. 25, 2022 | SCB | A randomized, placebo-controlled, double-blind, parallel escalation phase 1 clinical trial to assess the safety and tolerability of SCB after a single oral dose in healthy adult males and females. | Daegu Korean Medicine Hospital | Phase 1 | Daegu Haany University | |
| 11 | Hanpoong Pharm & Foods Ltd. | Feb. 23, 2018 | KCT-01 powder (KCT-01) | A randomized, placebo-controlled, double-blind, parallel escalation phase 1 clinical trial to assess the safety and tolerability of SCB after a single oral dose in healthy adult males and females. | Phase 1 | Kyunghee University | ||
| 10 | Hanpoong Pharm & Foods Ltd. | Dec. 13, 2017 | KCHO-1 (Mecasin) tablet | A manifold, double-blind, randomized, placebo-controlled, parallel phase 2b exploratory clinical trial to assess the efficacy and safety of Mecasin in combination with standard therapy (riluzole) in patients with amyotrophic lateral sclerosis. | Wonkwang University Sanbon Hospital/ Wonkwang University Gwangju Medical Center |
Stage 2b | Ongoing | Wonkwang University |
| 9 | Hanpoong Pharm & Foods Ltd. | Oct. 24, 2016 | H9 tablets | Open, dose-escalation, phase 1 clinical trial evaluating the oral safety of H9 in healthy adult volunteers. | (Educational institution) Dongguk University Bundang Oriental Hospital | Phase 1 | Dongguk University | |
| 8 | Hanpoong Pharm & Foods Ltd. | Nov. 17, 2015 | KCHO-1 (Mecasin) tablet | A phase 2a, parallel, double-blind, randomized, placebo-controlled, manifold clinical trial to evaluate the efficacy and safety of Mecasin plus standard treatment (riluzole) in patients with amyotrophic lateral sclerosis. | Wonkwang University Sanbon Hospital/ Wonkwang University Gwangju Medical Center |
2a상 | 2b after termination Ongoing |
Wonkwang University |
| 7 | Hanpoong Pharm & Foods Ltd. | Jul. 31, 2015 | Han Slim | A manifold, randomized, double-blind, placebo-controlled, multi-dose, parallel design phase 2b clinical trial to assess the efficacy and safety of Han Slim in obese patients for 12 weeks. | Kyunghee University Korean Medicine Hospital at Gangdong/ Kyunghee University Korean Medicine Hospital |
Stage 2b | Not completed | Kyunghee University |
| 6 | Hanpoong Pharm & Foods Ltd. | Apr. 14, 2015 | HPL-01 | Manifold, randomized, double-blind, placebo-controlled, dose-expanded, phase 2z clinical trial for the evaluation of the efficacy and safety of HPL-01 in patients with mild to moderate rheumatoid arthritis. | Wonkwang University Hospital/ Inje University Ilsan Paik Hospital/ Jeonbuk National University Hospital/ Soonchunhyang University Cheonan Hospital/ Hanyang University Guri Hospital |
Stage 2a | Suspended (No participants) |
Hanpoong Pharmaceutical |
| 5 | Hanpoong Pharm & Foods Ltd. | Mar. 06, 2015 | YG-1 tablets | A placebo-controlled, randomized, double-blind, phase 2 or higher clinical trial to assess the efficacy and safety of 1 g and 1.5 g of YG-1 in patients with acute sore throat. | Seoul National University Bundang Hospital | Phase 2 | Hanpoong Pharmaceutical | |
| 4 | Hanpoong Pharm & Foods Ltd. | Oct. 02, 2014 | BHH-10 | Evaluation of the efficacy and safety of BHH10 in patients with osteoporosis: Phase 2, manifold, randomized, placebo-controlled, double-blind clinical trial | Kyunghee University Korean Medicine Hospital at Gangdong/ Kyunghee University Hospital for Oriental Medicine |
Phase 2 | Not completed | Kyunghee University |
| 3 | Hanpoong Pharm & Foods Ltd. | Apr. 04, 2011 | Raphani semen tablet | Parallel design, short-term Phase 2 clinical trial to determine the dose and confirm the safety of oral administration of intravenous tablet as a combination therapy for mesalazine treatment in patients with mild to moderate ulcerative colitis. | Wonkwang University Hospital | Phase 2 | Hanpoong Pharmaceutical | |
| 2 | Hanpoong Pharm & Foods Ltd. | Aug. 24, 2009 | LMK02 | Phase 2 clinical trial investigating the safety and optimal dosage of LMK02 for mild to moderate Alzheimer's disease: Manifold, randomized, double-blind, multiple-dose, placebo-controlled study | Wonkwang University Sanbon Korean Medical Center | Phase 2 | ||
| 1 | Jul. 16, 2022 | HPL-01 | Manifold, randomized, double-blind, placebo-controlled, dose-exploration, phase 2a clinical trial to evaluate the efficacy and safety of HPL-01 in knee arthritis patients. | Seoul National University Bundang Hospital The Catholic University of Korea Uijeongbu St. Mary's Hospital Chung-Ang University Hospital |
Stage 2a | Ongoing | Hanpoong Pharmaceutical |